Are you the publisher? Claim or contact us about this channel


Embed this content in your HTML

Search

Report adult content:

click to rate:

Account: (login)

More Channels


Channel Catalog


Channel Description:

Daily news and press releases about Healthcare

older | 1 | .... | 1108 | 1109 | (Page 1110) | 1111 | 1112 | .... | 1118 | newer

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 07, 2018 ) Advancements in antibiotic residue diagnostics have extended their use of test kits to detect the presence of such residue in food originating from animals. The adoption of antibiotic residue test kits is gaining considerable traction as a food safety measure. Consumers are preferring products that have cleared the antibiotic residue tests, considering the role of these kits in ensuring that the food contains the essential antibiotic elements. Over the years, antibiotic residue test kits have evolved from simple diagnostic kits to multi-disciplinary tests that have incurred distinguished developments in terms of detecting the residues.

    Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=496

    According to Fact.MR’s latest forecast study, the global market for antibiotic residue test kits is pegged to expand robustly in the near future. Key findings from the report reveal that the global antibiotic residue test kits market will witness an expansion at 6.2% CAGR in terms of value over the forecast period, 2017-2026. The report further estimates that by the end of 2026, approximately US$ 295 Mn worth of antibiotic residue test kits will be sold worldwide.

    High Demand for Beta-lactams to Account for One-third Share of Global Market Value through 2026

    The report reveals that during the forecast period, beta-lactams tests will be predominantly used in detecting antibiotics residues in foods and beverages. By the end of 2026, nearly 33% of the overall global antibiotic residue test kits market revenues will be procured from the sales of beta-lactams test kits. The report also observes a surging adoption of tetracycline tests, and the sales of these kits are pegged to bring in more than US$ 50 Mn by the end of 2026. The report further projects that sulfonamide tests will register fastest revenue growth over the forecast period, reflecting a value CAGR of 7.1%.

    For more information on this report, please visit: https://www.factmr.com/report/496/antibiotic-residue-test-kits-market

    Food & Beverage Industry End-use to Translate High Revenue Growth

    In 2018 and beyond, antibiotic residue test kits will be predominantly used in the food and beverage industry. A range of antibiotic residue test kits are being used for ensuring safety of milk and other dairy products. Their use in inhibiting the growth of microorganisms through anti-infection principles will further extend their end-use in the global production of food items and beverages. By the end of 2026, the end-use of antibiotic residue test kits in global food & beverage industry will bring in revenues worth over US$ 196 Mn. The report also reveals that the veterinary end-use of antibiotic residue test kits will register fastest revenue growth at an estimated 6.7% CAGR over the forecast period.

    Competition Tracking

    Leading companies partaking in the development of antibiotic residue test kits have been profiled in this report. Companies namely, Thermo Fischer Scientific, DSM, Charm Sciences, Perkin Elmer (BioScientific Corp), Labtek Services Ltd., NEOGEN Food Safety, IDEXX Labs, R-Biopharm, Eurofins and Sciex are expected to instrument the global production of antibiotic residue test kits during the forecast period. Incorporating advancements in the field of antibiotic residue diagnostics will be prioritized by these market players. Moreover, several players in the global antibiotic residue test kits market will be eyeing at introducing multi-purpose kits in the near future.

    Make an inquiry for buying this report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=496

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us            
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 07, 2018 ) In order to study the many forthcoming movements and patterns prevailing in the global market, FactMR has included the latest Forecast report on Prefilled Auto Injectors Market to its vast database. The delivered study offers significant figures about the leading regions and applications which are functioning in the Prefilled Auto Injectors Market Upcoming Trends by 2022, along with their market production, consumption, revenue, upcoming industry trends and forecasted market share details. Further, the accomplished market research report also anticipates that the concerned market would grow at a constructive CAGR until 2022.

    Request Here for Free Sample of Global Market Research Report Now - https://www.factmr.com/connectus/sample?flag=S&rep_id=169

    Growing preference for convenient injection of anticoagulants and the introduction of a spectrum of new biotech products is reflecting favorably on the global prefilled auto-injectors market. Over the next couple of years, use of prefilled auto-injectors is expected become widespread across the globe. The product has made self-inject procedures extremely convenient for patients, hence, gaining a significant amount of user trust. In addition, the next generation prefilled auto injectors are more advanced in terms of technology and design. Manufacturers are actively focusing on perfecting prefilled auto-injectors in order to facilitate their use in new therapeutic areas.  Prefilled auto-injectors are essentially developed for more reliable and accurate injection. Factors as such are anticipated to further boost the global sales of prefilled auto-injectors. As per the latest report published by Fact.MR, the global prefilled auto injectors market is will surge at 15.3% CAGR during the forecast period (2017-2022).

    Prefilled auto-injectors are primarily intended for self-administration by patients without the obligation of any special training. These injectors come with standard prefilled barrels that contain therapeutic drugs and are easy to use. By design, they are mostly compact and have a pen like shape with a tiny reusable needle attached on the nip. Usually, the site of injection is either thighs or arms, but it may differ on a case-by-case basis or dosage of drug.

    North America Will Continue to Spearhead the Global Prefilled Auto-Injectors Market

    In terms of revenue, North America is expected to dominate the global prefilled auto-injectors market over 2022. This is primarily owing to the rising number of patients who require drug administration on regular basis. Owing to the extreme convenience of administrating insulin, prefilled auto injectors are also gaining popularity among patients suffering from diabetes in the region. The prefilled auto injectors market in North America in expected to witness a strong growth over the forecast period. Meanwhile, robust development of the healthcare sector coupled with low cost of prefilled auto-injectors is proving to be instrumental for the growth of the market in Asia-Pacific excluding Japan (APEJ). Between 2017 and 2022, the region’s market is projected to increase at an impressive CAGR of 15.9%.

    Browse Market Report with TOC Here - https://www.factmr.com/report/169/prefilled-auto-injectors-market

    Based on indication, the anaphylaxis segment currently accounts for more than two-third revenue share of the market. The segment is estimated to reach a market valuation of over US$ 3,187 Mn towards the end of 2022, reflecting a strong CAGR. In addition, the segment is expected to growing at around US$ 320 Mn annually over the course of the assessment period.

    Competition Tracking

    Fact.MR’s report also profiled companies that are expected to remain active in the expansion of global prefilled auto injectors market through 2022, which include Becton, Dickinson and Company, Pfizer Inc., Mylan N.V., Antares Pharma, Inc., Amgen Inc., and Eli Lilly and Company.

    Table of Content:

    Global Prefilled Auto-Injectors Market - Executive Summary
    Global Prefilled Auto-Injectors Market Overview
    2.1. Introduction

           2.1.1. Global Prefilled Auto-Injectors Market Taxonomy

           2.1.2. Global Prefilled Auto-Injectors Market Definition

    2.2. Global Prefilled Auto-Injectors Market Size (US$ Mn) and Forecast, 2012-2022

           2.2.1. Global Prefilled Auto-Injectors Market Y-o-Y Growth

    2.3. Global Prefilled Auto-Injectors Market Dynamics

    2.4. Regulations

    2.5. Supply Chain

    2.6. Cost Structure

    2.7. Average Pricing Analysis

    2.8. List of Distributors

    Continued…………………………

    Buy Hassle Free Global Market Research Report Here - https://www.factmr.com/checkout/169/S

    About Fact.MR

    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 07, 2018 ) An up-to-date research report has been disclosed by FactMR highlighting the titled “Urodynamic Devices Market: Expansion Strategies Set to Generate Substantial Revenue in the Near Future by 2022” which delivers an outlook of current market value as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR during 2017-2022. The report studies the Urodynamic Devices Market Worldwide, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions.

    Request 100 Page Sample Report from Here - https://www.factmr.com/connectus/sample?flag=S&rep_id=168

    Urodynamic study enables physicians in diagnosing causes, and identifying their nature, or detecting dysfunctions in the lower urinary tract. The primary objective of an urodynamic test is understanding disorders/problems occurring in lower urinary tract by duplication of symptoms. Urodynamic study also help in determination of the causes of bladder dysfunction, formulating an appropriate course for the treatment.

    According to the World Health Organization (WHO), 330,000 cases of bladder cancer have been diagnosed annually across the globe. In addition, the National Association of Incontinence has estimated 200 Mn people to be affected with urinary incontinence worldwide every year. These incidences have propelled demand for urodynamic devices, owing to rising clinical urgency. A number of healthcare initiatives are being taken for creating awareness about urological problems, along with the availability of treatment and diagnostics for urological disorders. For example, the initiative in Japan - “Let’s Talk and Think about Continence”, and the “Continence Awareness Week” conducted by Continence Foundation in the U.K. These initiatives have deprived people of the social stigma related to these problems, encouraging them to start consulting physicians, which in turn has been augmenting growth of the global urodynamic devices market.

    Moreover, a slew of technological advancements are being observed in urodynamic devices such as penile cuff, intravesical prostatic protrusion, condom catheter, and ultrasound video urodynamic. In addition, other factors such as surging availability of medical reimbursements pertaining to urological preliminary tests, continuous product approvals, and increasing proliferation of network of testing centers are further estimated to fuel demand for urodynamic devices around the world. The global market for urodynamic devices is projected to expand at an impressive CAGR during the forecast period 2017 to 2022, according to a recent research by Fact.MR. The market is estimated to account for revenues worth US$ 265 Mn by 2022-end.

    Competition Tracking

    Key players participating in the global urodynamic devices market include Albyn Medical Ltd., Boston Scientific Corporation, Medica SpA, Neomedix Systems Pty. Ltd., Dantec Dynamics A/S, CooperSurgical Inc., LABORIE, Verathon Inc., and Best Medical International Inc.

    To View Full Global Market Research Report Click Here - https://www.factmr.com/report/168/urodynamic-devices-market

    North America will retain its dominance in the global market for urodynamic devices, in terms of revenues. This is primarily attributed to surging prevalence of target diseases in the region, coupled with the robust adoption of urodynamic products in a variety of diagnostic procedures, pharmaceutical as well as healthcare centers, and rising preference of urologists & urogynecologists for urodynamic tests. Asia-Pacific excluding Japan (APEJ) is estimated to be the fastest expanding market for urodynamic devices over the forecast period. This robust expansion of the market in APEJ can be attributed to unmet patient requirements, rising prevalence of urological diseases, and increasing purchasing power of people in the region.

    Uroflowmetry urodynamic devices are projected to remain the top-selling device, accounting for over one-fourth revenue share of the market throughout the forecast period. This is mainly because of extensive utilization of uroflowmetry for diagnosis of benign prostatic hypertrophy, prostate cancer, neurogenic bladder, bladder dysfunction, bladder cancer, and urinary blockage. In addition, urodynamic catheters are estimated to be the fastest-selling device in the global urodynamic devices market during 2017 to 2022.

    Hospitals will continue to be the largest end-users of urodynamic devices, with sales poised to exceed US$ 150 Mn in revenues by 2022-end. Largest share of the revenues from sales of urodynamic devices in hospitals will be accounted by North America, representing over one-third share of the market. However, sales of urodynamic devices in urology clinics are anticipated to exhibit the highest CAGR through 2022, based on end-users.

    Buy Useful Figures about Global Market Report from Here - https://www.factmr.com/checkout/168/S

    About Fact.MR

    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400, Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) The Cancer Diagnostics Market can be divided on the basis of end-use industry, materials used, and applications. The few examples that are presumably going to influence the advancement of the market in a positive or negative way has also been included in this report.



    The essential purpose behind orchestrating the Cancer Diagnostics Market into segments helps the report in providing the readers with a comprehensive evaluation of the particular market and give an unmistakable understanding of the market as well.

    Get a Sample PDF Report: https://www.reportsweb.com/inquiry&RW00012287010/sample

    The Cancer Diagnostics market and its structure among the key players rely upon the activities performed by them independently nearby the total attempts of the new entrants and overall players. The report just focuses the assertions and settlements between market drivers to offer intensive components to readers on the true scene of the market.

    Market Segmentation:

    The market is differentiated into a number of segments like component, service, organization size, vertical, and region. The component segment is segmented into solution and services. The service segment is split into professional services and managed services. The market can be used in large, small, and medium-sized businesses. It is used in various different industries like Banking, Financial Services, & Insurance (BFSI), Retail & consumer goods, Healthcare & life sciences, Manufacturing, IT & telecommunications, and others.

    Leading Key Players:
    Becton, Dickinson and Company, GE Healthcare, Abbott, Roche, Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Illumina, Inc., Siemens Healthcare, C.R. Bard, Inc.,

    Get Discount on this Report: https://www.reportsweb.com/inquiry&RW00012287010/discount

    Market segment by Type, the product can be split into:
    Platform-based, Instrument-based,

    Market segment by Application, split into:
    Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma, Others,

    Cancer-Diagnostics-Market

    The competitive landscape:

    The competitive landscape of the Cancer Diagnostics market is a highly crucial section of the report that creates a firm portrait of the market’s key players and their rivalries. A reader can evaluate their position in the market using this scale of reference, while extensively planning their future movements to counter the movements of the other players in the same areas. This segment provides updated details on player profiles, business strategies, financial statistics, and the overall rate of growth and future potential for the leading players in the market, as well as the ones that show the most positive growth rates.

    Regional Analysis:

    The market is bifurcated into the number of key regions like North America, Europe, APAC, MEA, and Latin America. The use of cloud technologies in the APAC region is increasing tremendously. Therefore, the growth opportunities are more in this region. North America is considered to have the largest market share, while APAC is the region with the highest CAGR.



    Each analysis is based on highly researched sources of information and is combined with

    Competitor analysis
    R&D funding comparisons
    Novel and pipeline products
    Competitor business strategies
    Patent tracking
    Clinical trial information
    SWOT analysis
    Individual company reviews
    High impact tables and figures
    Key Issues Addressed:

    Competitive Landscape and Strategic Recommendations
    The market forecast and growth areas for Cancer Diagnostics Market
    Changing Market Trends and Emerging Opportunities
    Historical shipment and revenue
    Analysis of key applications
    Main Players market share.

    Overall the report offers detailed coverage of Cancer Diagnostics industry and presents main market trends. This research gives historical and forecasts market size, demand and production forecasts, end use demand details, price trends, and company shares of the leading Cancer Diagnostics producers to provide exhaustive coverage of the market.


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Womens Health Diagnostics Market by application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021", published by MarketsandMarkets™, The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.

    In this report, the global women health diagnostics market is segmented on the basis of application and end user. On the basis of application, the market is segmented into nine segments namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing. The breast cancer testing segment is further divided into mammography, tumor marker tests, blood cell count & blood chemistries, biopsies and other diagnostic imaging tests. Pregnancy and fertility testing market is sub segmented into lab-based testing, pregnancy self-test and ovulation prediction kits, ovulation prediction kits, fertility monitors and thermometers. The prenatal genetic screening & carrier testing segment is further divided into cystic fibrosis, Down syndrome and Edward syndrome, TORCH infections and others (fragile x-syndrome & tay-sachs diseases).

    Further on, the infectious disease testing market segment is sub segmented into methicillin-resistant staphylococcus aurea (MRSA), urinary tract infections (vaginal pH & vaginitis), hepatitis, tuberculosis, and others infectious disease testing. The sexually transmitted disease testing segment comprises Chlamydia Trachomatis and Neisseria Gonorrohoeae testing, HIV testing and other STD testing.. The ultrasound segment covers breast imaging and ob/gyn imaging. On the basis of end user, the women’s health diagnostics market is segmented into hospitals & clinics, home care, and diagnostic & imaging centers.

    Browse and in-depth TOC on “Women's Health Diagnostics Market”
    265 - Tables

    37 - Figures

    292 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html

    Major players in the global women’s health diagnostics market are Siemens AG (Germany), Quest Diagnostics Inc. (U.S.), Hologic, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), PerkinElmer Inc. (U.S.), Alere Inc. (U.S.), GE Healthcare (U.S.), Becton, Dickinson and Company (BD) (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), and Koninklijke Philips N.V. (Netherlands).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Pharmaceutical Robots Market by Type (Traditional Robots (Articulated Robots, SCARA Robots, Delta Robots, Cartesian Robots), Collaborative Robots), Application (Picking and Packaging, Laboratory Applications) - Global Forecast to 2021", published by MarketsandMarkets™, analyzes and studies the major market drivers, restraints, opportunities, and challenges.

    This report studies the global pharmaceutical robots market for the forecast period of 2016 to 2021. This market is expected to reach USD 119.5 Million by 2021 from USD 64.4 Million in 2016, at a CAGR of 13.2% during the forecast period. The key factor driving the growth of the market is the benefits offered by robotic systems in pharmaceutical manufacturing.

    The global pharmaceutical robots market is segmented on the basis of type, application, and region.

    Based on type, the market is segmented into traditional robots and collaborative robots. The traditional robots segment is expected to command the largest share of the global market. The traditional robots segment is further categorized into articulated, SCARA (selective compliance articulated robot arm), delta/parallel, Cartesian, and other robots (which include spherical and dual-arm robots). The articulated robots segment accounted for the largest share of the global pharmaceutical traditional robots market in 2016.

    Browse and in-depth TOC on “Pharmaceutical Robots Market”
    98 - Tables

    40 - Figures

    141 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pharmaceutical-robot-market-210985096.html

    Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB Ltd. (Switzerland), Denso Corporation (Japan), Seiko Epson Corporation (Japan), Marchesini Group S.p.A (Italy), Universal Robots A/S (Denmark), Yaskawa Electric Corporation (Japan), and Shibuya Corporation (Japan) are the prominent players in the global pharmaceutical robots market.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Pharmacy Automation Market by Product (Medication Dispensing System (Robot, Carousel), Packaging & Labeling System (Unit Dose, Multi Dose), Tabletop Counter, Storage System), End User (Inpatient, Outpatient, Retail Pharmacy) - Global Forecast to 2022", published by MarketsandMarkets™, The pharmacy automation market witnessed healthy growth rate during the last decade and is expected to grow at a CAGR of 8.2% between 2017 and 2022 to reach USD 5.38 Billion by 2022. The growth in this market is mainly attributed to factors such as growing need to minimize medication errors, rapid decentralization of pharmacies, rising geriatric population, and rising labor cost.

    The growing need to minimize medication errors, rapid decentralization of pharmacies, changing population demographics, and rising labor costs are the key factors driving the growth of this market

    Pharmacy automation systems refer to a variety of systems and software designed to increase the productivity of pharmacies and precision of the medication compounding process by reducing human intervention. Automated systems mechanize various procedures in pharmacies, including the storage, packaging, dispensing, pickup, delivery, and distribution of drugs.

    The pharmacy automation market has been segmented on the basis of product, into automated medication dispensing systems, automated packaging and labelling systems, automated table top counters, automated medication compounding systems, automated storage and retrieval systems, and other pharmacy automation systems. The market for automated packaging and labelling systems is expected to grow at the highest CAGR between 2017 and 2022. On the other hand, among all the products, automated medication dispensing systems are most widely used. The high adoption of these instruments is contributing to the rapid growth of the market.

    Browse and in-depth TOC on “Pharmacy Automation System Market”
    181 - Tables

    54 - Figures

    218 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/pharmacy-automation-systems-market-71522890.html

    The major players in the pharmacy automation market are Becton, Dickinson, and Company (U.S.), Omnicell, Inc. (U.S.), Cerner Corporation (U.S.), Capsa Healthcare (U.S.), Parata Systems LLC (U.S), Baxter International, Inc. (U.S.), ScriptPro LLC (U.S.), KUKA AG (Germany), TCGRx Pharmacy Workflow Solutions (U.S.), RxSafe, LLC (U.S.), ARxIUM Inc. (U.S.) and Talyst systems LLC. (U.S.). These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new technologies and products in the market.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “IV Equipment Market by Product (Infusion Pump, Catheter, Solution and Blood Administration Set, Securement Device, Cannula, Stopcock, Needleless Connector), End User (Hospitals & Clinics, Homecare, Ambulatory Care Center) - Global Forecast to 2022", published by MarketsandMarkets™, The global IV equipment market is expected to reach USD 13.63 Billion by 2022 from USD 10.07 Billion in 2017, at a CAGR of 6.2% from 2017 to 2022.

    Increasing incidence of chronic diseases and rising geriatric population, growing number of surgical procedures performed, rising demand for ambulatory infusion pumps due to the growing home care market, rising number of needlestick injuries and infections are the key factors driving the growth of this market.

    Intravenous (IV) therapy devices are used to administer liquid substances directly into a vein. They can deliver nutrients or medications such as insulin or other hormones, antibiotics, chemotherapy drugs, and pain relievers. These devices offer significant advantages over manual fluid administration, including the ability to deliver fluids in very small volumes and at precisely programmed rates or automated intervals. These devices are also used for blood transfusion.

    The IV equipment market has been segmented, on the basis of product into IV catheters, administration sets, infusion pumps, securement devices, stopcocks & check valves, drip chambers, needleless connectors, and other IV equipment. The market for securement devices is expected to grow at the highest CAGR between 2017 and 2022. Increasing adoption of central venous catheter securement devices and peripheral IV catheter securement devices during IV therapy owing to the advantages such as water resistant and can be repositioned upon initial application.

    Browse and in-depth TOC on “IV Equipment Market”
    102 - Tables

    38 - Figures

    166 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/iv-equipment-market-78345313.html

    Market Players

    Becton, Dickinson and Company (U.S.), B. Braun Melsungen AG (Germany), Baxter International Inc. (U.S.), Fresenius SE & Co. KGaA (Germany), ICU Medical, Inc. (U.S.) held the major share of the IV equipment market and will continue to dominate the market between 2017 and 2022. Other major players operating in this market are Smiths Medical (U.K.), Moog, Inc. (U.S.), Terumo Corporation (Japan.), C. R. Bard, Inc. (U.S.), and AngioDynamics, Inc. (U.S.).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report "Computer Assisted Coding Market by Software (Natural Language Processing, Structured Input, Integrated Systems), Service (Support, Education & Training), Application (Automated Encoding, Clinical Coding Audit, Management Reporting) - Global Forecast to 2022", published by MarketsandMarkets™, The global computer-assisted coding market is valued at USD 2.76 Billion in 2017 and is expected to register a CAGR of 11.5% to reach to USD 4.75 Billion by 2022.

    Computer assisted coding software are used to improve maximize the revenue of organisation by reducing coding errors and maximizing claims reimbursement cycle. Some commonly used computer assisted coding software includes standalone and integrated software. Standalone software is used only for encoding and integrated software is integrated with EHR/EMR, encoder system, voice/text/speech recognition software, CDI, transcription system, and other HIM applications.
    The computer assisted coding market has been segmented, on the basis of software and service. The software segment is subsegmented into standalone software and integrated software. The market for integrated computer-assisted coding software segment is expected to grow at the highest CAGR between 2017 and 2022. The growing need for optimized computer-assisted coding software for seamless workflow and successful data integration within healthcare provider systems contribute to the rapid growth of the market.
    Browse and in-depth TOC on " Computer Assisted Coding Market "

    202 - Tables
    40 - Figures
    242 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/computer-assisted-coding-market-170644018.html

    Key players in the market include 3M Health Information Systems (US), Optum (US), McKesson Corporation (US), Nuance Communications (US), Cerner Corporation (US), Dolbey Systems (US), Precyse Solutions (nThrive) (US), Craneware (UK), Artificial Medical Intelligence (US), and TruCode (US). Other players include Quest Diagnostics (US), Streamline Health Solutions (US), M-scribe Technologies (US), eZDI Inc. (US), Alpha II LLC. (US), ID GmbH & Co. KGaA (Germany), ZyDoc (US), Coding Strategies (US), Patient Code Software (US), and Flash Code (US) among others. These players are increasingly undertaking mergers and acquisitions, and product launches to develop and introduce new computer assisted coding solutions in the market.
    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA : 1-888-600-6441
    Email: mailto:sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com/



    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.

    Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology. This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market. Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology. The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.
    Based on tools, the synthetic biology market is subsegmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids. The oligonucleotides segment is expected to account for the largest share of the market in 2017 owing to the rising demand for synthetic DNA, RNA, and genes, which are used in a wide range of applications, such as pharmaceuticals, nutraceuticals, personal care, flavors and fragrances, probiotics, green chemicals, and industrial enzymes.
    Browse and in-depth TOC on “Synthetic Biology Market”
    162 - Tables

    32 - Figures

    214 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.html

    The US is expected to dominate the synthetic biology market in 2017

    In 2017, the US is estimated to account for the largest share among other regions in the synthetic biology market, followed by the UK and Germany. The dominant share of the US is attributed to factors such as increased demand for bio-based products, increased investments in synthetic biology companies, and rising R&D funding for synthetic biology.

    The major players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023", published by MarketsandMarkets™, The global bioinformatics market is projected to reach USD 13.50 billion in 2023 from USD 7.73 billion in 2018, at CAGR of 14.5%. Growing demand for nucleic acid and protein sequencing, initiatives from government and private organizations, growing applications of bioinformatics, and the increasing number of collaborations between companies and research institutes are the major factors driving the growth of the market.

    On the basis of product & service, the market is broadly segmented into knowledge management tools, bioinformatics platforms, and services. The bioinformatics platform segment is projected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the increasing usage of different bioinformatics platforms in various genomic and proteomics applications. Additionally, there is an increase in the use of bioinformatics platforms in drug discovery and development, which also contributes to the growth of the market.

    Browse and in-depth TOC on “Bioinformatics Market”
    189 - Tables

    27 - Figures

    195 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/bioinformatics-39.html

    Market Players

    The bioinformatics market is highly competitive due to the presence of a large number of players. Few of the major companies in bioinformatics market are Thermo Fisher Scientific (US), Illumina Inc (US), Agilent Technologies (US), QIAGEN (Netherlands), BGI (China), Wuxi NextCODE (China), Eurofins Scientific (Luxembourg), Waters Corporation (US), Sophia Genetics (Switzerland), Partek (US), and DNASTAR (US).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Medical Aesthetics Market Product (Botox, Dermal Filler, Liposuction, Cellulite Reduction, Fat Reduction, Skin Tightening, Breast Implant, Tattoo Removal, Thread Lift), End User (Clinic, Medical Spa, Hospital, Beauty Center) - Global Forecast to 2023", published by MarketsandMarkets™, The global medical aesthetics market is projected to reach USD 17.07 billion by 2023 from USD 10.30 billion in 2018, at a CAGR of 10.6%.

    On the basis of products, the market is segmented into facial aesthetic products (dermal fillers, botulinum toxin, microdermabrasion, and chemical peels); body contouring devices (nonsurgical fat reduction devices, cellulite reduction devices, and liposuction devices); cosmetic implants [breast implants (silicone implants and saline implants), facial implants, and other cosmetic implants]; hair removal devices (laser hair removal devices and IPL hair removal devices); skin aesthetic devices (laser resurfacing devices, nonsurgical skin tightening devices, micro-needling products, and light therapy devices); tattoo removal devices; thread lift products; physician-dispensed cosmeceuticals and skin lighteners; physician-dispensed eyelash products; and nail treatment laser devices. The facial aesthetic products segment is expected to hold the largest share of the medical aesthetics market in 2018.

    The large share of this segment is attributed to the growing patient demand for facial aesthetic treatments, increasing disposable income and spending capabilities, and the rising geriatric population across the globe.

    Browse and in-depth TOC on “Medical Aesthetics Market”
    93 - Tables

    39 - Figures

    184 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/medical-aesthetics-market-885.html

    Product launches, enhancements, and product approvals are the key growth strategies adopted by major players to strengthen their position in the global medical aesthetics market. In addition, strategies such as agreements, partnerships, and collaborations; acquisitions; and expansions were also adopted by several market players to remain competitive in the market.

    Allergan, plc (Ireland), Alma Lasers, Ltd. (Israel), Anika Therapeutics (US), Cutera, Inc. (US), Cynosure (US), El.En. S.p.A. (Italy), Fotona d.o.o. (Slovenia), Nestlé S.A. (Switzerland), Johnson & Johnson (US), Merz Pharma GmbH & Co. KGaA (Germany), Medytox, Inc. (South Korea), Sientra, Inc. (US), Sinclair Pharma PLC (UK), Syneron Medical, Ltd. (US), and Valeant Pharmaceuticals International, Inc. (US) are some of the key players operating in the global medical aesthetics market.

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 07, 2018 ) The research report on Small Molecule Targeted Cancer Therapy market has adopted a systematic way to evaluate the dynamics of the overall market. This study report on Global Small Molecule Targeted Cancer Therapy Market throws light on the crucial trends and dynamics impacting the development of the market, including the restraints, drivers, opportunities, industry trends, market size, Application, market share estimates and profiles of the leading industry Players. The fundamental purpose of Small Molecule Targeted Cancer TherapyMarket report is to provide a correct and strategic analysis of the industry.The report also analyzes the development proposals and the feasibility of new investments.

    Get Sample Copy @ https://www.reportsweb.com/inquiry&RW00012328008/sample

    The Global Small Molecule Targeted Cancer Therapy Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancement. This report has been collated in order to provide guidance and direction to the companies and individuals interested in buying this research report.

    Major Players in Small Molecule Targeted Cancer Therapy market are:
    Boehringer Ingelheim, Bayer HealthCare, OncoGenex Pharmaceuticals, Abbott Laboratories, GlaxoSmithKline, Cytokinetics, Hospira

    Major Regions play vital role in Small Molecule Targeted Cancer Therapy market are:
    North America, Europe, China, Japan, Middle East & Africa, India, South America, Others.

    Most important types of Small Molecule Targeted Cancer Therapy products covered in this report are:
    Monoclonal Antibodies, Small Molecules, Small Molecule Drug Conjugates, Get Up-to 50% Discount for this report: https://www.reportsweb.com/inquiry&RW00012328008/discount

    The Small Molecule Targeted Cancer Therapy Market Report mainly covers following Content:

    Important changes in market dynamics.
    Market Competition by Manufacturers.
    Competitive landscape of Small Molecule Targeted Cancer Therapy market.
    Manufacturers Profiles/Analysis.
    In-depth market segmentation
    Strategies of key players and product offerings.
    Industry Effect Factors Analysis, Overview.
    Manufacturing Cost Analysis.
    Market Analysis by Application
    Market Manufacturers Profiles/Analysis
    Market Development Status and Outlook
    Small Molecule Targeted Cancer Therapy Market Forecast 2022.

    Reasons to Purchase Small Molecule Targeted Cancer Therapy Market Report:

    -Current and future of Small Molecule Targeted Cancer Therapy Market outlook in the developed and emerging markets.
    -Analysis of various perspectives of the market with the help of Porter’s five forces analysis.
    -The segment that is expected to dominate the Small Molecule Targeted Cancer Therapy Market.
    -Regions that are expected to witness the fastest growth during the forecast period.
    -Identify the latest developments, Small Molecule Targeted Cancer Therapy Market shares, and strategies employed by the major market players.

    Access Full Report Description, TOC and Table of Figure @ https://www.reportsweb.com/global-small-molecule-targeted-cancer-therapy-industry-market-research-report


    Rajat Sahni
    +1-646-491-9876
    sales@reportsweb.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Autoinjectors Market by Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Cardiovascular diseases, Psoriasis, Migraine), Type (Disposable, and Reusable), End Users (Homecare, and Hospitals) - Global Forecast to 2023", published by MarketsandMarkets™, The global autoinjectors market is projected to reach USD 85.31 billion by 2023 from an estimated USD 28.91 billion in 2018, at a CAGR of 24.2% during the forecast period (2018-2023). The key factors driving the growth of this market include the growing prevalence of targeted therapies such as rheumatoid arthritis and multiple sclerosis, rising incidence of anaphylaxis, and increasing number of regulatory approvals.

    By therapy, the rheumatoid arthritis segment is expected to account for the largest share of the market in 2018

    On the basis of therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, diabetes, anaphylaxis, and other therapies such as migraines, cardiovascular diseases, psoriasis, and anemia. In 2018, the rheumatoid arthritis segment is expected to account for the largest share of the global market. The large share of this segment can be primarily attributed to the high prevalence of rheumatoid arthritis across the globe.

    Browse and in-depth TOC on “Autoinjectors Market”
    66 - Tables

    36 - Figures

    133 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/autoinjector-market-173991724.html

    North America to dominate the market in 2018

    In 2018, North America is expected to account for the largest share of the autoinjectors market, followed by Europe. Factors such as increasing geriatric population in Canada, increasing FDA approvals, rising prevalence of anaphylaxis in the US, and rising prevalence of autoimmune and chronic diseases in the US and Canada are contributing to the large share of North America.

    The key players in the global autoinjectors market are Abbvie (US), Amgen (US), Teva (Israel), Biogen (US), Eli Lilly (US), and Mylan (US). The other prominent players in the market are J&J (US), Novartis (Switzerland), Bayer (Germany), Merck (Germany), Biogen (US), Ypsomed (Switzerland), SHL Group (Taiwan) Becton, Dickinson and Company (US), Owen Mumford (UK), Novartis (Switzerland), and Haselmeier (Switzerland).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Particle Therapy Market by Type (Heavy Ion, Proton Therapy), Products (Cyclotron, Synchrotron, Synchrocyclotron), Services, System (Single-room, Multi-room), Cancer Type (Pediatric, Prostate, Breast), Application (Treatment, Research) - Forecast to 2023", published by MarketsandMarkets™, The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.

    By product, the synchrotron segment is expected to grow at the highest rate during the forecast period
    Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen. The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.

    By type, proton therapy is expected to be the largest contributor to the particle therapy market
    The large share of the proton therapy segment can be attributed to factors such as the high degree of precision, shorter treatment time, and reduced side-effects associated with proton therapy as compared to conventional photon therapies using X-rays. Other factors such as the increasing research activities in the field of radiation oncology using proton therapy systems, rising number of proton therapy centers, and longer equipment lifespan of proton therapy (30 years or more) in comparison to photon therapy (10 years) are expected to support the growth of this market in the coming years.

    Browse and in-depth TOC on “Particle Therapy Market”
    80 - Tables

    36 - Figures

    138 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/particle-therapy-market-12809137.html

    The major players operating in the particle therapy market are Ion Beam Applications SA (Belgium), Varian Medical Systems, Inc. (US), Hitachi, Ltd. (Japan), Provision Healthcare (US), Mevion Medical Systems, Inc. (US), Sumitomo Heavy Industries, Ltd. (Japan), Optivus Proton Therapy, Inc. (US), ProTom International, Inc. (US), Advanced Oncotherapy plc (UK), and Danfysik A/S (Denmark).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

     



    (EMAILWIRE.COM, December 08, 2018 ) According to the new market research report “Genotyping Market by Technology (PCR, Sequencing, Microarray, Electrophoresis, MALDI-TOF), Application (Pharmacogenomics, Diagnostic Research, Animal Genetics, Agricultural Biotechnology), and Product - Global Forecast to 2023", published by MarketsandMarkets™, The genotyping assay market is expected to reach USD 31.9 billion by 2023 from an estimated USD 11.8 billion in 2018, at a CAGR of 22.0%.

    The major factors driving the growth of this market include technological advancements, the decreasing prices of DNA sequencing, and the increasing incidence of genetic diseases.

    Based on technology, the genotyping assay market is segmented into PCR, microarrays, sequencing, capillary electrophoresis, MALDI-TOF, and other technologies. The sequencing segment is expected to account for the largest share of the global genotyping market during the forecast period of 2018 to 2023. The large share of this segment can be attributed increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, the decreasing cost of DNA sequencing per genome, and the growing uptake of the hybrid approach of sequencing.

    Browse and in-depth TOC on “Genotyping Market”
    219 - Tables

    53 - Figures

    280 - Pages

    View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/genotyping-market-249958595.html

    North America, the largest regional market for genotyping

    North America is expected to account for the largest share of the genotyping assay market in 2018, followed by Europe and the Asia Pacific. The increasing adoption of technologically advanced genotyping products, the high healthcare expenditure, presence of advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, large number of genotyping-based R&D projects, and the presence of a large number of leading genotyping manufacturers in the region, along with an increasing demand from pharmaceutical companies for genotyping products and rising investments by government bodies, are responsible for the large share of the North American genotyping market.

    The prominent players in the genotyping assay market are Thermo Fisher Scientific (US), Illumina (US), QIAGEN (Netherlands), Agilent Technologies (US), Danaher Corporation (US), Roche Diagnostics (Switzerland), GE Healthcare (US), Fluidigm Corporation (US), PerkinElmer (US), Eurofins Scientific (Luxembourg), Bio-Rad Laboratories (US), Pacific Biosciences of California (US), GENEWIZ (US), and Integrated DNA Technologies (US).

    About MarketsandMarkets™

    MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

    Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

    MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

    Contact:

    Mr. Shelly Singh
    MarketsandMarkets™ INC.
    630 Dundee Road
    Suite 430
    Northbrook, IL 60062
    USA: 1-888-600-6441
    Email: sales@marketsandmarkets.com
    Visit Our Website: https://www.marketsandmarkets.com


    Mr. Shelly Singh
    1-888-600-6441
    sales@marketsandmarkets.com

    Source: EmailWire.Com

    0 0

    (EMAILWIRE.COM, December 07, 2018 ) The global market size of Animal Pharm Antibiotics is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.

    To know more about Animal Pharm Antibiotics,
    Get Sample Copy Of Report At https://www.researchreportsinc.com/sample-request?id=79907 .

    There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.

    The Major Players Companies include:
    Mujo International Ltd, Letdooo, Serfas, Planet Bike, Blitzu, Magnus Innovation et al.

    Furthermore, years considered for the study are as follows:
    Historical year – 2013
    Base year – 2018
    Forecast period – 2018 to 2023

    If Any Query,
    Ask Customization At https://researchreportsinc.com/enquiry?id=79907 .

    For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented from 2013 to 2023.

    This report covers following regions:
    North America
    South America
    Asia & Pacific
    Europe
    MEA (Middle East and Africa)

    The key countries in each region are taken into consideration as well, such as United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

    To Avail Discount,
    Click At https://www.researchreportsinc.com/check-discount?id=79907 .

    For end use/application segment, this report focuses on the status and outlook for key applications. End users also can be listed.
    For competitor segment, the report includes global key players of Animal Pharm Antibiotics as well as some small players.

    The information for each competitor includes:
    Company Profile
    Main Business Information
    SWOT Analysis
    Sales, Revenue, Price and Gross Margin
    Market Share

    Table of contents
    Chapter 1: Executive Summary
    Chapter 2: Abbreviation and Acronyms
    Chapter 3: Preface
    Chapter 4: Market Landscape
    Chapter 5: Market Trend Analysis
    Chapter 6: Industry Chain Analysis
    Chapter 7: Latest Market Dynamics
    Chapter 8: Trading Analysis
    Chapter 9: Historical and Current Animal Pharm Antibiotics Market in North America (2013-2018)
    Chapter 10: Historical and Current Animal Pharm Antibiotics Market in South America (2013-2018)
    Chapter 11: Historical and Current Animal Pharm Antibiotics Market in Asia & Pacific (2013-2018)
    Chapter 12: Historical and Current Animal Pharm Antibiotics Market in Europe (2013-2018)
    Chapter 13: Historical and Current Animal Pharm Antibiotics Market in MEA (2013-2018)
    Chapter 14: Summary for Animal Pharm Antibiotics Market (2013-2018)
    Chapter 15: Animal Pharm Antibiotics Market Forecast (2019-2023)
    Chapter 16: Company Profile

    Buy Now https://researchreportsinc.com/checkout/?add-to-cart=79907&&attribute_pa_choose-license=single-user&&quantity=1 .

    Contact Us
    David,
    Deals Manager,
    US/Canada: +1-855-419-2424
    UK: +4403308087757
    Email: sales@reseasrchreportsinc.com







    Shubham Goel
    8554192424
    sales@researchreportsinc.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 08, 2018 ) Fact.MR has published a new research report titled “Vocal Biomarker Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2027” to its online database that tries to unveil the various scenarios prevailing in the Vocal Biomarker Market. This assessment delivers a smart compilation of primary and secondary data which provides a clear insight about the future plans expected to impact the Vocal Biomarker Market. This study comprises of prominent data which makes it a beneficial source for investors, analysts and industry experts to acquire necessary knowledge associated to the fundamental market trends, opportunities and growth drivers during the stated forecast period. 

    Request For Free Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=719

    According to a recent research analysis, sound vibrations, which were employed as therapeutic healing for mental health conditions, are now witnessing application into various disease diagnostics including psychiatric and cardiovascular ailments. Post-successful execution of clinical trials, HIPAA-compliant vocal biomarkers are set to serve as effective alternatives to currently available disease diagnostic systems such as CT scan, MRI and X-ray.

    Prominent voice-based companies such as IBM Corporation, Cogito Corporation, Audio Profiling, Sonde Health, and Beyond Verbal are focusing on sampling data for providing accurate results. For example – Beyond Verbal has been taking immense research efforts on vocal biomarkers and has compiled over 2.5 Mn samples of voice in more than 40 different languages.

    Site Management by CROs Essential for Ensuring Vocal Biomarker Clinical Trails’ Success

    Contract research organizations (CROs) are likely to spearhead the global vocal biomarker market, in terms of revenues as well as growth rate. Given the expanding range of voice-assistant, health-related applications, life sciences and healthcare organizations have commenced designing an array of scenarios to deploy voice assistant platforms in clinical trial settings. Integration of these platforms in the research for vocal biomarkers has the potential to address specific drawbacks in current clinical trial environment.

    CROs are essential and play a key role in ensuring the clinical trials’ success through proper site management. Accurate level of site management & oversight prompts site to effectively recruit, train, and retain subjects, meanwhile ensuring overall management of subjects, protocol adherence, and regulatory compliance. CROs help in maintaining and improving the communication flow, thereby reducing protocol deviations & violations, and addressing data issues & queries. These benefits of CROs also effectively apply to quality and integrity of clinical trials apropos of vocal biomarkers.

    Leveraging Product Development to Enhance Collaboration

    Product development prevails as an imperative strategy driving collaborating between leading companies and research institutes across various sectors, and healthcare is no exception, Apropos of vocal biomarkers, Beyond Verbal has developed “Beyond mHealth Research Platform”, which aims at collaborating with universities, businesses, hospitals, and research institutes for collectively developing unique vocal biomarkers.

    Another leading player, Sonde Health Inc., has introduced voice-based technology platform that enables diagnosing and monitoring various conditions and diseases. The company has collaborated with Massachusetts Institute of Technology (MIT) for licensing the technology. Such collaborations and developments will lead to better solutions and more accurate results for patients. It will further encourage researchers and institutions worldwide in collecting voice data for disease diagnostics and improving outcome of patients.

    Browse Full Report with TOC @ https://www.factmr.com/report/719/vocal-biomarker-market

    Virtual Private Assistants Enabling Voice-based Emotion Detection

    Current digital world is making rapid transformations in the way people interact with technology and one another, with virtual private assistants taking on a personalized experience. As virtual private assistants such as Amazon’s Alexa become more popular & useful and smarter, developers are focusing on providing them with additional tools that enable recognizing emotions. A prime example of such development is the cloud-based API engine by Beyond Verbal, which integrates with the virtual private assistants (VPAs).

    The aim of Beyond Verbal’s project is to enhance the sensitivity of one’s connected home. Focus of this cloud-based API engine is directed toward eliminating VPAs’ emotional blind spots, given that the vocal intonations in human communication represent 35-40% of emotions conveyed. Future developments of vocal biomarkers is likely to enable VPAs analyze voice for the specific health conditions, providing unique insights into remote health monitoring and personalized tech.

    A recently compiled report of Fact.MR envisages the global vocal biomarker market to record a spectacular 23.3% CAGR between the forecast period 2018 and 2027. Revenues from global sales of vocal biomarkers are foreseen to surpass US$ 390 Mn by 2027-end. Beyond Verbal, Sonde Health, IBM Corporation, and other leading participants operating in the global vocal biomarker market have been profiled and analyzed in detail in the report.

    Non-invasiveness of Vocal Biomarker in Psychiatric Disorder Diagnostics in Sync with Self-diagnosis’ Upward Trend

    Sound vibrations have been employed as biomarkers for diagnosing psychiatric disorders such as depression and anxiety. Similar distinctive features, known as vocal biomarkers, have been recently discovered by scientists that might pose a massive influence on developing a diagnostic tool. Additionally, latest research analyses have greatly impacted application of vocal biomarkers in diagnosing psychiatric ailments ranging from stress to Parkinson’s disease.

    Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders. Moreover, these significant user-friendly tools fall perfectly in line with the upward trend of self-diagnosis, which in turn has considerably fuelled their demand across the globe. Psychiatric disorders are likely to remain the leading indication in the global vocal biomarker market, with revenues estimated to rake in approximately US$ 130 Mn by 2027-end.

    Table of Content:

    Global Vocal Biomarker Market – Executive Summary
    Global Vocal Biomarker Market Outlook Overview
    2.1. Introduction
    2.2. Market Definition
    2.3. Vocal Biomarker Market- Opportunity Assessment (US$ Mn)
    2.4. Trends and Developments
    2.5. Competitive Analysis (Fortune Wheel)
    Market Dynamics
    3.1. Key Growth Drivers
         3.1.1. Drivers
         3.1.2. Restraints
           3.1.3. Opportunities
           3.1.4. Trends
    3.2. Supply Chain
    3.3. Cost Structure
    3.4. Forecast Scenario
    3.5. Forecast Factors and Relevance of Impact
    3.6. Key Takeaways for Vocal Biomarker Market
    3.7. Epidemiology
    3.8. Investment Feasibility Matrix
    3.9. PEST Analysis
    3.10. Product Life Cycle Analysis
    3.11. Competition Footprint Matrix
    3.12. Porter's Five Forces Analysis
    3.13. Key Participants Market Presence (Intensity Map) By Region
    Continued……………

    Have Any Query? Discuss with Our Expert Team @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=719

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Read Industry News at- https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 08, 2018 ) North America continues to stay at the vanguard of the neonatal monitoring equipment market, with an estimated market value share of over one-third through the period of forecast. Rate of premature birth has been steadily rising in North America over the past couple of years, according to the CDC, which in turn has increased the number of NICU admissions, thereby creating demand for neonatal monitoring equipment.

    Speciality of hospice and palliative medicine has gained significant recognition in North America, with attendant increase in training programs at both academic and clinical level. The imperative role of palliative care in improving growth development outcomes in newborn babies has been highly recognized in the region’s NICUs for reducing the infant and neonatal mortality rates.

    Know the methodology behind the report @ https://www.factmr.com/connectus/sample?flag=RM&rep_id=746

    Neonatal monitoring has transformed into a multidisciplinary field that involves unique integration of intelligence from technology, design, medical science & social study. Mounting pressures for leveraging new technologies in order to offer cost-effective, more efficient, and safer neonatal care have made the neonatal intensive care units (NICUs) smarter.

    Advancements in monitoring technologies and their growing deployments in NICUs is a key factor enabling faster & easier measurement of myriad physiological parameters in neonates. Current neonatal monitors incorporate several features including ECG recordings, oxygen saturation over time, respiratory rate & air flow, and invasive arterial blood pressure.

    Value-based healthcare models have led the development of NICU centers that are well equipped with monitoring & diagnostic devices, coupled with rising number of FDA approvals for these devices. Additionally, gradually increasing awareness on excessive sensory stimuli, discomfort, and procedural pain has been driving the demand for non-obtrusive neonatal monitoring technologies. Demand for neonatal brain monitoring equipment featuring video recording devices will also gain high traction in the near future.

    Predictive Monitoring Gains Ground in Neonatal Monitoring

    Several parameters and data points are gathered and centrally managed during NICU admissions, which comprise physiological parameters, sensor readings, device data, and interventions and observations of caregivers. High data volume generated in NICUs are leveraged for predictive monitoring that involves physiological data analysis for identifying infants at high risk, thereby enabling early detection of ailments.

    View Full Report with TOC @ https://www.factmr.com/report/746/neonatal-monitoring-equipment-market

    Researchers have developed an ECG for continuous analysis of transient decelerations and low heart rate variability for computing heart rate characteristics index (HeRO). This developments aids in early detection of sepsis in newborn babies. Attempts have also been made for using parameters in the detecting apneas of premature infants. Although challenges persist in predictive monitoring and proper training is required for relevant caregivers, this approach has potential for treating life-threatening ailments earlier, thereby improving outcomes in neonatal care.

    Pulse Oximetry Perceives High Traction by Providing Safety Net for Neonates in NICUs

    Pulse oximetry, a prominent patient monitoring technology, is providing safety for infants and newborns in NICUs, while new advancements in home monitoring enable data transmission of neonates’ vital data to smartphones. The Centers for Disease Control and Prevention (CDC) has slated screening newborns by using pulse oximeters to be beneficial & effective in identifying numerous life-threating conditions. In current-world healthcare facilities, effective patient monitoring technology is highly bound to effective respiratory care.

    When it comes to monitoring newborn babies, particularly in NICUs, extra care & safety is essential, which is often delivered through pulse oximetry. The non-invasive nature of pulse oximetry has made it ideal for application in newborns. Several hospitals have been employing pulse oximeters as the standard of care in their NICUs. For example, the NICU at Pennsylvania-based Reading Hospital utilizes Philips Healthcare’s IntelliVue Monitors, and Covidien’s Nellcor pulse oximeters to ensure positive outcomes for newborn babies.

    Table of Content:

    1. Executive Summary
    1. Highlighting Action Area – Wheel of Fortune
    1.2. Opportunity Analysis
    Global neonatal monitoring equipment market Overview
    2.1. Introduction
    2.2. Market Definition
    2.3. Market Taxonomy and Segments Captured
    Global Neonatal Monitoring Equipment Market Outlook
    3.1. Market Size (US$ Mn) & Volume (Units) and Forecast, 2013-2028
    3.2. Market Y-o-Y Growth
    3.3. Forecast Factors
    Global Neonatal Monitoring Equipment Market Dynamics
    4.1. Drivers
    4.2. Restraints
    4.3. Opportunities
    4.4. Trends
    Pricing and Supply Chain Analysis
    Actionable Insights and Analysis
    6.1. Porter’s Five Forces Analysis
    6.2. Scenario Forecast
    6.3. PEST Analysis
    6.4. Global Neonatal Mortality Rate Since 2000
    6.5. Neonatal Mortality Rates By Region 2016
    6.6. Major Reasons Behind Neonatal Deaths
    6.7. Grades of Neonatal Care
    Global Neonatal Monitoring Equipment Market Analysis and Forecast By Type, 2013-2028
    7.1. Analysis and Forecast By Product Type
         7.1.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Region
         7.1.2. Market Share Comparison, By Region
           7.1.3. Y-o-Y growth Comparison, By Region
    7.2. Analysis and Forecast By End User
           7.2.1. Revenue (US$ Mn) & Volume (Units) Comparison, By Region
           7.2.2. Market Share Comparison, By Region
    Continued……………..

    Grow Your Business From Expert Advice @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=746

    About FactMR
    FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Read Industry News at- https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

    0 0

     

    Fact.MR




    (EMAILWIRE.COM, December 08, 2018 ) Success of biologic drugs, owing to their capability to treat chronic diseases, has taken the pharmaceutical industry to a new level. Biologics, offering enhanced curing abilities without side effects are being widely used to treat chronic ailments such as cancer and other autoimmune diseases. With FDA approval, several companies have been introducing novel biologic drugs for various therapeutic areas. This has made delivery of biologics an important aspect.

    Get Free Exclusive Sample Copy of This Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=603

    With growing innovations in drug delivery systems, for instance adoption of prefilled syringes, the administration of biologics has been convenient and effective. Novel drug delivery systems such as prefilled syringes have gained high traction as effective delivery systems especially for injectable drugs. Moreover, prefilled syringes are aiding in delivery of personalized drugs specifically tailored for small patient populations.

    According to research on prefilled syringes by Fact.MR, the global prefilled syringes market is expected to expand at a value CAGR of 9.6% during the period of forecast, 2017-2026. By end of 2026, more than 10,200,000 thousand units of prefilled syringes are expected to be sold across the globe in various healthcare facilities. Key companies involved in the global prefilled syringes market include Becton Dickinson and Company, Terumo Medical Corporation, Baxter International Inc., Medtronic and Gerresheimer. 

    Increasing Use of Glass Prefilled Syringes to Aid the Growth of the Global Prefilled Syringes Market

    Prefilled syringes come in two types of material, namely plastic and glass. Glass prefilled syringes are a widely used drug injectable system for parenteral drugs owing to its compatible features, for instance, higher stability, oxygen permeability and non-reactive nature. However, the main challenge of glass prefilled syringes is their fragile nature. Glass prefilled syringes require high caution while storing or transportation, in the absence of which, loss of injectable drugs can take place. On the other hand, plastic prefilled syringes are also witnessing increased demand, with introduction of advanced plastic material that removes the chances of reaction of drug with inner walls of the syringe, thereby maintaining the pH level of the medicine.

    For more information on this report, please visit: https://www.factmr.com/report/603/prefilled-syringes-market

    Use of advanced polymer material, for instance, crystal-clear polymer and polypropylene, have increased the adoption of plastic prefilled syringes. These advanced plastic material being biocompatible, do not initiate chemical activity within the syringe. Moreover, chance of breakage is removed with the use of plastic prefilled syringes. However, majority of prefilled syringes are made of glass, and sales of glass prefilled syringes are expected to sky rocket in the coming years.

    Sale of Prefilled Syringes in North America to Remain at the Forefront, as Compared to Other Regions

    According to Prefilled Syringes West Coast Conference held in 2017, the use of prefilled syringes in North America have gained high demand with increasing need for safety, patient satisfaction and high quality. Counters in North America, especially the United States, are reflecting higher expenditure on injectable drug delivery systems, for instance development of composite polymer prefilled syringes. These syringes have high break resistance. In addition the needle is attached with use of insert molding procedure, thus eliminating the use of tungsten and glue, increasing their sterilization levels.

    The prevalence of chronic diseases in United States and Canada, according to analysis of American Heart Association, is increasing owing to increased use of tobacco and smoking. This has made it imperative for pharmaceutical companies in this region to develop novel biologics to fight against chronic disorders such as cancer. This is expected to fuel the adoption of efficient drug delivery systems such as prefilled syringes in the coming years.

    Make an inquiry for buying this report @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=603

    About Fact.MR

    Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

    Contact Us            
    FactMR
    11140 Rockville Pike
    Suite 400
    Rockville, MD 20852
    United States
    Email: sales@factmr.com
    Web: https://www.factmr.com/
    Blog: https://factmrblog.com/
    Read Industry News at - https://www.industrynewsanalysis.com/


    James Hilton
    +353-1-6111-593
    info@factmr.com

    Source: EmailWire.Com

older | 1 | .... | 1108 | 1109 | (Page 1110) | 1111 | 1112 | .... | 1118 | newer